Bordeaux, France

Sergio Vitiello

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sergio Vitiello

Introduction

Sergio Vitiello is a distinguished inventor based in Bordeaux, France, who has made significant strides in the field of medical research. With a portfolio of two patents, his work primarily revolves around the innovative use of antagonists of the CB1 receptor, addressing a variety of medical conditions.

Latest Patents

Sergio's latest patents focus on the development of antagonists of the CB1 receptor. This invention is intended for use in the treatment of several pathological conditions, including but not limited to bladder and gastrointestinal disorders, inflammatory diseases, cardiovascular diseases, nephropathies, glaucoma, cancer, metabolic disorders, and various psychiatric and neurological disorders. His research addresses critical health issues such as obesity, addiction, pain management, and neurodegenerative disorders, showcasing the potential of his inventions in multifaceted therapeutic applications.

Career Highlights

Vitiello has had a commendable career, functioning in notable institutions such as Université de Bordeaux and the Institut National de la Santé et de la Recherche Médicale. His position in these esteemed organizations has enabled him to spearhead research that bridges gaps in medical science and aids in the advancement of treatment methodologies.

Collaborations

Throughout his career, Sergio has collaborated with prominent researchers, including Pier Vincenzo Piazza and Monique Vallee. These collaborations reflect a synergy of expertise and innovation, bolstering the impact of his research and broadening the scope of his inventions.

Conclusion

In summary, Sergio Vitiello's contributions as an inventor reinforce the importance of innovative research in addressing complex medical challenges. His patents on the antagonists of the CB1 receptor are poised to make a significant impact on the treatment of various disorders, highlighting the dynamic nature of invention and the ever-evolving landscape of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…